Navigation Links
University of Nevada School of Medicine researcher reviews muscular dystrophy therapies
Date:6/22/2012

RENO, Nev. Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine.

"This is a focus article in which we summarize the impact of MG53 protein therapy as a treatment option and discuss the increasing number of new protein therapeutics being developed for the muscular dystrophies, including laminin-111 developed in our laboratory," Burkin, a pharmacological researcher and associate professor, said.

The article, "A Molecular Bandage for Diseased Muscle," co-authored by Ryan Wuebbles, a post-doctoral student in Burkin's lab in the University's Center for Molecular Medicine, is a review of the current status of therapeutic developments in the muscular dystrophy research field. These therapies represent significant strides and show great promise in treatment of muscular dystrophy.

Approaches to treat Duchenne muscular dystrophy include gene replacement therapy, gene repair and myoblast cell transfer.

In a study on MG53 by Noah Weislander and colleagues, presented in the same issue of Science Translational Medicine, it was found that mice that lack MG53 developed progressive muscle weakness and exhibit defective muscle repair after exercise or injury, and that MG53 facilitates rapid membrane repair to prevent damage to normal muscle.

The study suggests that treatment in combination with other protein therapies such as Burkin's laminin-111 therapy, are likely to have synergy as well for Duchenne and other muscular dystrophies.

Burkin's published research on laminin-111, a naturally occurring protein, showed it is quickly picked up in the bloodstream of mice and prevents muscle damage, an important finding for Duchenne muscular dystrophy, the most common form of muscular dystrophy.

He recently co-hosted Myomatrix 2012, a conference for leading muscular dystrophy scientists and clinicians to explore and share their latest findings and data on treatment breakthroughs. The conference was held at the University of Nevada, Reno campus, where research by Burkin has led to a potential new therapy for muscular dystrophy.


'/>"/>
Contact: Mike Wolterbeek
mwolterbeek@unr.edu
University of Nevada, Reno
Source:Eurekalert  

Related medicine news :

1. Arizona State University secures defense contract
2. Wayne State University researcher examines proteins role in diabetic retinopathy
3. University Hospitals Case Medical Center experts present at ASCO Annual Meeting
4. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
5. McMaster University researchers discover drug destroys human cancer stem cells but not healthy ones
6. University studies and career expectations of medical students
7. University of Minnesota startup to treat challenging bacterial infection
8. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
9. University of Houston Graduate College of Social Work announces partnership with MD Anderson
10. Neuropsychologist receives University of Houstons highest faculty honor
11. Louisiana Tech University professor earns NSF Early Career Development grant
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of Nevada School of Medicine researcher reviews muscular dystrophy therapies
(Date:9/11/2019)... , ... September 11, 2019 , ... ... exhibit at the 2019 AHIMA Health Data and Information Conference in Chicago, Illinois ... by booth #505 to learn more about GRM’s healthcare information management solutions ...
(Date:9/11/2019)... ... September 11, 2019 , ... Autopsies don’t lie. ... injury to the body. , Methamphetamine permanently harms the heart. It increases risks ... getting a better understanding of how the damage occurs. , An August ...
(Date:9/11/2019)... ... 2019 , ... Ahipoki is excited to announce a new vegan and gluten ... vegetarians, pescatarians and poke bowl fans alike. Ahimi is made of five simple ... texture similar to tuna, Ahipoki customers will now have a vegan option ...
(Date:9/11/2019)... ... ... Women’s Excellence is excited to announce the opening of their new Royal ... Royal Oak, MI 48073 in the heart of Royal Oak off Woodward Avenue south ... a contemporary, spa-like atmosphere. We are thrilled to be in a great, central ...
(Date:9/11/2019)... , ... September 10, 2019 , ... ... Doctors by Pasadena Magazine. These physicians have been recognized among the best doctors ... pediatric subspecialties:, Robert H. Cho, M.D. – Chief ...
Breaking Medicine News(10 mins):
(Date:9/17/2019)... ... September 17, 2019 , ... Called Muss-Bits (Musical Sensory Substitution Bits) it ... Design Awards Students category. , It was developed by Associate Professor Suranga Nanayakkara and ... is comprised of two parts. A “sensor bit” that can be placed on or ...
(Date:9/17/2019)... ... September 17, 2019 , ... ... to establish a new partnership with NextGen Healthcare Inc., a leading healthcare solutions ... partners, which include Nextech, DrChrono, Symplast and Azalea, with additional partnerships to announce ...
(Date:9/17/2019)... CHERRY HILL, N.J. (PRWEB) , ... September 17, ... ... of Canal Calem Periodontics located in Moorestown and Medford, NJ, now welcome patients ... team of periodontists strives to save natural teeth whenever possible. When tooth removal ...
Breaking Medicine Technology: